Furthermore, we analyzed the effects of the Tissue inhibitor of metalloproteinase 3 (TIMP3), which is an endogenous potent metalloprotease inhibitor implicated in AD pathogenesis [21, 22], on secreted APP669-711 levels from Neuro2a cells (Fig. 3D). This evidence concerns the gene TIMP3 and Alzheimer disease.